Pero Hrabač

Dr. Pero Hrabač


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Danijela ŠtanfelDanijela Štanfel
Danijela Štanfel
LKLivije Kalogjera
Livije Kalogjera
SRSergey Ryazantsev
Sergey Ryazantsev
KHKristina Hlača
Kristina Hlača
ERElena Radtsig
Elena Radtsig
PHPero Hrabač
Pero Hrabač
The history of saline nasal irrigation (SNI) is indeed a long one, beginning from the ancient Ayurvedic practices and gaining a foothold in the west at the beginning of the 20th century. Today, there is a growing number of papers covering the effects of SNI, from in vitro studies to randomized clinical trials and literature overviews. Based on the recommendations of most of the European and American professional associations, seawater, alone or in combination with other preparations, has its place in the treatment of numerous conditions of the upper respiratory tract (URT), primarily chronic (rhino)sinusitis, allergic rhinitis, acute URT infections and postoperative recovery. Additionally, taking into account its multiple mechanisms of action and mounting evidence from recent studies, locally applied seawater preparations may have an important role in the prevention of viral and bacterial infections of the URT. In this review we discuss results published in the past years focusing on seawater preparations and their use in clinical and everyday conditions, since such products provide the benefits of additional ions vs. saline, have an excellent safety profile and are recommended by most professional associations in the field of otorhinolaryngology.

21 March 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
Danijela ŠtanfelDanijela Štanfel
Danijela Štanfel
LKLivije Kalogjera
Livije Kalogjera
SRSergey Ryazantsev
Sergey Ryazantsev
KHKristina Hlača
Kristina Hlača
ERElena Radtsig
Elena Radtsig
PHPero Hrabač
Pero Hrabač
The history of saline nasal irrigation (SNI) is indeed a long one, beginning from the ancient Ayurvedic practices and starting to gain a foothold in the west at the beginning of 20th century. Today, there is a growing number of papers covering effects of SNI from in vitro studies to randomized clinical trials and literature overviews. Based on the recommendations of most of the European and American professional associations, seawater, alone or in combination with other preparations, has its place in treatment of numerous conditions of the upper respiratory tract (URT), primarily in chronic (rhino)sinusitis, allergic rhinitis, acute URT infections and postoperative recovery. Additionally, taking into account its multiple mechanisms of action and mounting evidence from recent studies, locally applied seawater preparations may have an important role in prevention of viral and bacterial infections of the URT. Therefore, in this review we discuss results published in the past years focused on the seawater preparations and their use in clinical and everyday conditions, since such products are superior to saline, have an excellent safety profile and are recommended by most professional associations in the field of otorhinolaryngology.

18 February 2025 in Genes
Verified
Journal Article
Open access
PDF file
IČIvana Čulav
Ivana Čulav
MSMihael Skerlev
Mihael Skerlev
LSLidija Žele Starčević
Lidija Žele Starčević
PHPero Hrabač
Pero Hrabač
SHSuzana Ljubojević Hadžavdić
Suzana Ljubojević Hadžavdić
Liborija Lugović-MihićLiborija Lugović-Mihić
Liborija Lugović-Mihić
Background: Human papillomavirus (HPV) infections in men remain under-researched despite their critical role in disease transmission and the increasing incidence of HPV-related cancers. This study investigates the clinical and molecular characteristics of anogenital HPV infections in men, emphasizing genotype prevalence, diagnostic methods, and lesion variability. Methods: A cross-sectional study was conducted on 70 men aged 18–65 years with clinically diagnosed anogenital HPV infection. Lesions were characterized by morphology and location. HPV DNA was analyzed using INNO-LiPA (INNOvative Line Probe Assay), Hybrid Capture II (HC II), and polymerase chain reaction (PCR) assays to determine genotype distribution. Associations between clinical features and HPV genotypes were assessed using multivariate statistical analyses. Results: Lesions varied in morphology, with verrucous (52.86%) and papular (30%) types being the most common. Localization patterns showed predominance on the penis radix (34.29%) and shaft (27.14%). Molecular testing revealed HPV DNA in 88.57% of the cases using INNO-LiPA, compared to 45% and 40% with HC II and PCR, respectively. Low-risk (LR) genotypes, particularly HPV6, dominated single infections, comprising 68.57% of the cases, while high-risk (HR) genotypes accounted for 20%. Mixed LR and HR infections were observed in 14.29% of the lesions, with greater diversity noted in distal genital regions. Notably, condyloma plana and lesions on the inner prepuce exhibited a higher prevalence of HR and mixed infections. Age and lesion duration showed trends toward older patients and longer disease duration in cases involving perianal and extragenital condylomas, though these findings were not statistically significant. No direct correlation between lesion type or localization and specific genotypes was identified, underscoring the heterogeneity of HPV clinical manifestations in men. Conclusions: Anogenital HPV infections in men exhibit significant heterogeneity in lesion morphology, localization, and genotype distribution. HR HPV genotypes were detected in a notable proportion of benign lesions, underscoring their potential role in disease progression. INNO-LiPA proved superior in diagnostic accuracy, highlighting the need for standardized and cost-effective diagnostic approaches for men. Further research is crucial to elucidate HPV’s clinical impact in men and inform prevention and treatment strategies.

25 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KJKarla Misura Jakobac
Karla Misura Jakobac
Vibor MilunovićVibor Milunović
Vibor Milunović
VKVesna Kušec
Vesna Kušec
PHPero Hrabač
Pero Hrabač
MMMarko Martinović
Marko Martinović
GPGordana Pavliša
Gordana Pavliša
Background/Objectives: In hematological patients receiving treatment for lymphomas, febrile neutropenia (FN) is a serious complication associated with significant morbidity and mortality. This prospective study aimed to evaluate the diagnostic and prognostic value of the novel biomarker presepsin (PSP) in episodes of FN in this specific cohort of patients. Methods: The study enrolled 37 patients with FN and 18 patients with neutropenia without fever as a control group. Patients with FN were divided into two groups: those with confirmed infections and those without them. Various clinical and laboratory parameters were analyzed, including inflammatory and biochemical markers, focusing on implications of PSP. Results: Among patients with FN, 65% had proven infections with significantly higher PSP levels compared to those without infections and control group (p < 0.001). Positive blood cultures were found in 13.5% of all FN episodes. PSP showed greater sensitivity than traditional biomarkers like procalcitonin and C-reactive protein for differentiating septic from non-septic complications. Increased PSP levels at admission suggested a poorer survival prognosis. Each 1 ng/mL increase in PSP correlated with a 5% increase in mortality risk (HR 1.05; p < 0.001), with a one-year mortality rate of 56.7%, underscoring the necessity for better predictive markers. Other markers, including CRP, PCT, IgG, and albumin, were not significantly associated with mortality; however, platelets and qSOFA exhibited borderline significance. Conclusions: PSP is a valuable biomarker for identifying high-risk FN in lymphoma patients and predicting mortality, correlating with infection severity. Larger multi-center studies are needed to validate these findings and optimize PSP’s clinical application to improve outcomes.

29 June 2023 in Medicina
Verified
Journal Article
Open access
PDF file
MFManuela Filipec
Manuela Filipec
VBVladimir Blagaić
Vladimir Blagaić
MĐMarinela Jadanec Đurin
Marinela Jadanec Đurin
PZPaulo Zekan
Paulo Zekan
PHPero Hrabač
Pero Hrabač
AZAna Zovko
Ana Zovko
Background and Objectives: Functional status of the mother after delivery is crucial for performing activities of daily living and caring for the newborn. It is important to assess functional abilities after childbirth in order to improve the quality of postpartum care. The aim of this study is to determine the psychometric properties of the questionnaire and assess the functional abilities after childbirth. Materials and Methods: This study is observational. Postpartum Functional Assessment Questionnaire includes eleven items. 301 women after childbirth, 234 after vaginal birth and 67 after caesarean section participated in the study. An assessment of pain intensity and functional abilities was performed on the first and third day after childbirth. The Factor and Cronbach’s alpha analyses were performed to determine the factor structure and internal consistency. Results: The analysis reveals two factors, with seven items loading on factor 1 and four on factor 2. Cronbach’s alpha for construct I (Mobility) at the first day was 0.927 and at the third day was 0.913; and for Factor II (Self-care) at the first day was 0.846 and at the third day was 0.894. All between-group differences in pain intensity and functional abilities were highly statistically significant (p < 0.001). Differences between the first and third postpartum day were statistically significant for all variables and all subgroups (p < 0.001). Conclusions: Postpartum Functional Assessment Questionnaire has good psychometric properties and is a valuable tool for use in clinical practice.

21 March 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
Katarina Fehir ŠolaKatarina Fehir Šola
Katarina Fehir Šola
PHPero Hrabač
Pero Hrabač
Urszula ReligioniUrszula Religioni
Urszula Religioni
LPLjubica Frančić Pranjković
Ljubica Frančić Pranjković
Piotr MerksPiotr Merks
Piotr Merks
Background/Objective: Pharmacists are among the most accessible healthcare professionals, playing a crucial role in public health. In response to the ongoing COVID-19 pandemic, many countries, including Croatia, have expanded the responsibilities of pharmacists. Since November 2021, Croatian pharmacists have been authorized to provide COVID-19 testing in community pharmacies. This study explores patients’ perceptions of these pharmacy-based testing services. Methods: This study employed a quantitative research approach, utilizing a structured questionnaire as the primary data collection tool. The research was conducted between November 2021 and January 2022, with a total of 211 participants from diverse backgrounds. Results: The findings demonstrate a highly positive perception of COVID-19 testing services in community pharmacies. A significant majority (95.2%) of patients found pharmacist-administered testing to be convenient. Additionally, 92.3% believed that pharmacists possess the necessary skills to perform the tests, and 94.7% expressed willingness to undergo testing in a pharmacy again. Notably, 94% of respondents indicated their intention to utilize pharmacists’ services for future testing. Conclusions: Croatian patients exhibit a strong positive attitude towards pharmacist-led COVID-19 testing in community pharmacies. These findings highlight the pivotal role of pharmacists in enhancing healthcare accessibility and demonstrate the value of integrating pharmacy-based testing services into public health strategies. This study provides valuable insights into the evolving role of pharmacists in healthcare delivery.